Nov 13, 2013
13_IMM_04_Immatics and Roche sign cancer vaccine and immunotherapy collaboration (PDF, 133 KB)
13_IMM_04_Immatics und Roche unterzeichnen Kollaboration zur Entwicklung von Krebsimpfstoffen und Krebsimmuntherapien (PDF, 138 KB)
Press contact, Immatics Biotechnologies GmbH
+49 7071 5397-0 media@immatics.com
Always up to date: Receive posts from us and our partners via our Twitter profile.
Find out more about Immatics on LinkedIn with our News, Events & Press Releases.
Follow us on Xing: Receive corporate updates around our technologies and collaborations.
Go back
